Ain Shams University: Carcinoma, Hepatocellular trials

The registry lists 13 Carcinoma, Hepatocellular studies with Ain Shams University as lead sponsor. 2 are open to participants now and 1 have results posted.

Phase 3 2Phase 4 3No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Evaluation of Efficacy and Safety of Immune Check Point Inhibitors in Hepatocellular Carcinoma Patients in Ain Shams University HospitalsEnrolling by invitationNCT07088081
• Anti-cancer Potentiality of Saffron Against Hepatocellular CarcinomaNot yet recruitingNCT06464380Phase 4
• Efficacy and Safety of Drug Eluting Beads TACE in Treatment of HCC in Egyptian PatientsCompletedNCT03007225Phase 4Results posted
• Implication of Long Non-coding RNA HOTTIP Haplotype on Liver Cancer MetastasisCompletedNCT06544005
• Recurrence Rate of Hepatocellular Carcinoma After Treatment of Chronic Hepatits C Patients With Direct Acting Antivirals: Randomized Controlled Phase 3 TrialStatus unknownNCT03551444Phase 3
• Golgi Protein for HCC DiagnosisCompletedNCT03039322
• Outcome of Transarterial Chemo-embolization (TACE) in Hepatocellular Carcinoma Patients With Partial Portal Vein ThrombosisCompletedNCT03007212Phase 4
• Efficacy of Loco-regional Treatment for Hepatocellular Carcinoma Prior to Living Donor Liver Transplantation in EgyptCompletedNCT02990351
• Sorafenib Versus Best Supportive Care in Egyptian Hepatocellular Carcinoma Patients.CompletedNCT02971696Phase 3
• Annexin A2 as a Novel Diagnostic Marker in Hepatocellular CarcinomaCompletedNCT02541149
• Single Center Experience Over a Decade in Living Donor Liver Transplantation for Egyptian Patients With Hepatocellular Carcinoma: Stretching the LimitsCompletedNCT01937286
• Recurrence of Hepatocellular CarcinomaCompletedNCT01520779
• Procalcitonin in Hepatocellular CarcinomaCompletedNCT01518829